The FDA has cleared three antimicrobial susceptibility tests that will be available to guide physicians towards the appropriate usage of Baxdela™ (delafloxacin). Baxdela, available from Melinta Therapeutics in both intravenous and oral forms, is an FDA-approved fluoroquinolone indicated in adults for the treatment of acute bacterial skin and skin structure infections … more

Separately, Melinta announced the successful completion of its merger with Cempra … more